MELILLO, ROSA MARINA
MELILLO, ROSA MARINA
DIPARTIMENTO DI MEDICINA MOLECOLARE E BIOTECNOLOGIE MEDICHE
Molecular mechanisms of RET activation in human cancer
2002 Santoro, Massimo; Melillo, Rosa Marina; Carlomagno, F; Fusco, Alfredo; Vecchio, Giancarlo
Ret-mediated mitogenesis requires Src kinase activity.
1999 Melillo, Rosa Marina; Barone, Mv; Lupoli, G; Cirafici, Am; Carlomagno, F; Visconti, R; Matoskova, B; Di Fiore, Pp; Vecchio, G; Fusco, Alfredo; Santoro, Massimo
Tyrosine 1062 of RET-MEN2A mediates activation of Akt(PKB) and MAPK pathways leading to PC12 cell survival.
2000 DE VITA, G; Melillo, ROSA MARINA; Carlomagno, C; Visconti, R; Castellone, Md; Bellacosa, A; Billaud, M; Fusco, Alfredo; Tsichlis, Pn; Santoro, Massimo
Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2).
2003 Carlomagno, F; Vitagliano, D; Guida, T; Basolo, F; Castellone, Md; Melillo, ROSA MARINA; Fusco, Alfredo; Santoro, Massimo
Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes.
2003 Castellone, Md; Cirafici, Am; DE VITA, G; DE FALCO, V; Malorni, L; Tallini, G; Fagin, Ja; Fusco, Alfredo; Melillo, ROSA MARINA; Santoro, Massimo
The neuron-specific Rai (ShcC) adaptor protein inhibits apoptosis by coupling Ret to the phosphatidylinositol 3-kinase/Akt signaling pathway.
2002 Pelicci, G; Troglio, F; Bodini, A; Melillo, ROSA MARINA; Pettirossi, V; Coda, L; DE GIUSEPPE, A; Santoro, Massimo; Pelicci, Pg
Tumor Suppressor Role of Formyl Peptide Receptor 1 in Human Gastric Cancer
2014 Prevete, Nella; Liotti, F.; Visciano, C.; Marone, G.; DE PAULIS, Amato; Melillo, ROSA MARINA
Therapeutic strategies to target the receptor tyrosine kinase AXL in thyroid cancer
2012 Gnanaprakasam, Krisnamoorthy; Guida, Teresa; Visciano, Carla; Liotti, Federica; Carlomagno, Francesca; Melillo, ROSA MARINA
Peptide per rigenerare i tessuti lesionati.
2009 DE PAULIS, Amato; Marone, Gianni; Romano, M; Melillo, ROSA MARINA; Montuori, Nunzia; Staibano, Stefania; D'Argenio, Giuseppe; Prevete, Nella; Rossi, FRANCESCA WANDA; Rivellese, Felice; Salerno, F.
Functional role of the CXCR4 chemokine receptor in thyroid cancer.
2009 Melillo, ROSA MARINA
Molecular basis of thyroid cancer: role of inflammatory cells and molecules
2008 Melillo, ROSA MARINA
Molecular mechanisms of RET activation in human neoplasia
2002 Santoro, Massimo; Carlomagno, F; Melillo, Rosa Marina; Vecchio, Giancarlo; Fusco, Alfredo
Cytokines, Chemokines and thyroid remodeling
2008 Melillo, ROSA MARINA
Small-molecule inhibitors of chemokine receptors as novel anticancer therapy of human thyroid carcinomas.
2007 V., Guarino; Avilla, Elvira; Bertini, R.; Allegretti, M.; Santoro, Massimo; Melillo, ROSA MARINA
Tyrosine kinase oncoprotein, RET/PTC3, induces the secretion of myeloid growth and chemotactic factors.
2003 Russell, Jp; Shinohara, S; Melillo, ROSA MARINA; Castellone, Md; Santoro, Massimo; Rothstein, Jl
Protein kinase Calpha activation by RET: evidence for a negative feedback mechanism controlling RET tyrosine kinase.
2003 Andreozzi, F; Melillo, ROSA MARINA; Carlomagno, F; Oriente, F; Miele, C; Fiory, Francesca; Santopietro, S; Castellone, Md; Beguinot, F; Santoro, M; Formisano, P.
The ret/ptc oncogene is activated in familial adenomatous polyposis-associated thyroid papillary carcinomas.
1998 Cetta, F; Chiappetta, G; Melillo, ROSA MARINA; R. M, Petracci; M, Montalto; G, Santoro; M, Fusco
The tyrosine kinase oncoprotein, RET/PTC3, induces the secretion of myeloid growth and chemotactic factors.
2003 Russell, Jp; Shinohara, S; Melillo, ROSA MARINA; Castellone, Md; Santoro, M; Rothstein, J.
Glial cell line-derived neurotrophic factor induces proliferative inhibition of NT2/D1 cells through RET-mediated up-regulation of the cyclin-dependent kinase inhibitor p27(kip1).
2002 Baldassarre, G; Bruni, P; Boccia, A; Salvatore, G; Melillo, ROSA MARINA; Motti, Ml; Napolitano, M; Belletti, B; Fusco, Alfredo; Santoro, M; Viglietto, G.
Human N-ras, TRK-T1, and RET/PTC3 oncogenes, driven by a thyroglobulin promoter, differently affect the expression of differentiation markers and the proliferation of thyroid epithelial cells
1999 Portella, Giuseppe; Vitagliano, D; Borselli, C; Melillo, ROSA MARINA; Salvatore, Domenico; Rothstein, Jl; Vecchio, G; Fusco, Alfredo; Santoro, M.
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Molecular mechanisms of RET activation in human cancer | 2.1 Contributo in volume (Capitolo o Saggio) | 2002 | Santoro, Massimo; Melillo, Rosa Marina; Carlomagno, F; Fusco, Alfredo; Vecchio, Giancarlo | |
| Ret-mediated mitogenesis requires Src kinase activity. | 1.1 Articolo in rivista | 1999 | Melillo, Rosa Marina; Barone, Mv; Lupoli, G; Cirafici, Am; Carlomagno, F; Visconti, R; Matoskova, B; Di Fiore, Pp; Vecchio, G; Fusco, Alfredo; Santoro, Massimo | |
| Tyrosine 1062 of RET-MEN2A mediates activation of Akt(PKB) and MAPK pathways leading to PC12 cell survival. | 1.1 Articolo in rivista | 2000 | DE VITA, G; Melillo, ROSA MARINA; Carlomagno, C; Visconti, R; Castellone, Md; Bellacosa, A; Billaud, M; Fusco, Alfredo; Tsichlis, Pn; Santoro, Massimo | |
| Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2). | 1.1 Articolo in rivista | 2003 | Carlomagno, F; Vitagliano, D; Guida, T; Basolo, F; Castellone, Md; Melillo, ROSA MARINA; Fusco, Alfredo; Santoro, Massimo | |
| Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes. | 1.1 Articolo in rivista | 2003 | Castellone, Md; Cirafici, Am; DE VITA, G; DE FALCO, V; Malorni, L; Tallini, G; Fagin, Ja; Fusco, Alfredo; Melillo, ROSA MARINA; Santoro, Massimo | |
| The neuron-specific Rai (ShcC) adaptor protein inhibits apoptosis by coupling Ret to the phosphatidylinositol 3-kinase/Akt signaling pathway. | 1.1 Articolo in rivista | 2002 | Pelicci, G; Troglio, F; Bodini, A; Melillo, ROSA MARINA; Pettirossi, V; Coda, L; DE GIUSEPPE, A; Santoro, Massimo; Pelicci, Pg | |
| Tumor Suppressor Role of Formyl Peptide Receptor 1 in Human Gastric Cancer | 4.2 Abstract in Atti di convegno | 2014 | Prevete, Nella; Liotti, F.; Visciano, C.; Marone, G.; DE PAULIS, Amato; Melillo, ROSA MARINA | |
| Therapeutic strategies to target the receptor tyrosine kinase AXL in thyroid cancer | 4.2 Abstract in Atti di convegno | 2012 | Gnanaprakasam, Krisnamoorthy; Guida, Teresa; Visciano, Carla; Liotti, Federica; Carlomagno, Francesca; Melillo, ROSA MARINA | |
| Peptide per rigenerare i tessuti lesionati. | 6.1 Brevetto | 2009 | DE PAULIS, Amato; Marone, Gianni; Romano, M; Melillo, ROSA MARINA; Montuori, Nunzia; Staibano, Stefania; D'Argenio, Giuseppe; Prevete, Nella; Rossi, FRANCESCA WANDA; Rivellese, Felice; Salerno, F. | |
| Functional role of the CXCR4 chemokine receptor in thyroid cancer. | 8.10 Tesi di Dottorato | 2009 | Melillo, ROSA MARINA | |
| Molecular basis of thyroid cancer: role of inflammatory cells and molecules | 8.10 Tesi di Dottorato | 2008 | Melillo, ROSA MARINA | |
| Molecular mechanisms of RET activation in human neoplasia | 2.1 Contributo in volume (Capitolo o Saggio) | 2002 | Santoro, Massimo; Carlomagno, F; Melillo, Rosa Marina; Vecchio, Giancarlo; Fusco, Alfredo | |
| Cytokines, Chemokines and thyroid remodeling | 8.02 Comunicazioni a Convegni o Seminari | 2008 | Melillo, ROSA MARINA | |
| Small-molecule inhibitors of chemokine receptors as novel anticancer therapy of human thyroid carcinomas. | 8.02 Comunicazioni a Convegni o Seminari | 2007 | V., Guarino; Avilla, Elvira; Bertini, R.; Allegretti, M.; Santoro, Massimo; Melillo, ROSA MARINA | |
| Tyrosine kinase oncoprotein, RET/PTC3, induces the secretion of myeloid growth and chemotactic factors. | 1.1 Articolo in rivista | 2003 | Russell, Jp; Shinohara, S; Melillo, ROSA MARINA; Castellone, Md; Santoro, Massimo; Rothstein, Jl | |
| Protein kinase Calpha activation by RET: evidence for a negative feedback mechanism controlling RET tyrosine kinase. | 1.1 Articolo in rivista | 2003 | Andreozzi, F; Melillo, ROSA MARINA; Carlomagno, F; Oriente, F; Miele, C; Fiory, Francesca; Santopietro, S; Castellone, Md; Beguinot, F; Santoro, M; Formisano, P. | |
| The ret/ptc oncogene is activated in familial adenomatous polyposis-associated thyroid papillary carcinomas. | 1.1 Articolo in rivista | 1998 | Cetta, F; Chiappetta, G; Melillo, ROSA MARINA; R. M, Petracci; M, Montalto; G, Santoro; M, Fusco | |
| The tyrosine kinase oncoprotein, RET/PTC3, induces the secretion of myeloid growth and chemotactic factors. | 1.1 Articolo in rivista | 2003 | Russell, Jp; Shinohara, S; Melillo, ROSA MARINA; Castellone, Md; Santoro, M; Rothstein, J. | |
| Glial cell line-derived neurotrophic factor induces proliferative inhibition of NT2/D1 cells through RET-mediated up-regulation of the cyclin-dependent kinase inhibitor p27(kip1). | 1.1 Articolo in rivista | 2002 | Baldassarre, G; Bruni, P; Boccia, A; Salvatore, G; Melillo, ROSA MARINA; Motti, Ml; Napolitano, M; Belletti, B; Fusco, Alfredo; Santoro, M; Viglietto, G. | |
| Human N-ras, TRK-T1, and RET/PTC3 oncogenes, driven by a thyroglobulin promoter, differently affect the expression of differentiation markers and the proliferation of thyroid epithelial cells | 1.1 Articolo in rivista | 1999 | Portella, Giuseppe; Vitagliano, D; Borselli, C; Melillo, ROSA MARINA; Salvatore, Domenico; Rothstein, Jl; Vecchio, G; Fusco, Alfredo; Santoro, M. |